Literature DB >> 12454279

Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL.

Zoulika Zak1, Laurent Lagrost, Thomas Gautier, David Masson, Valérie Deckert, Linda Duverneuil, Jean-Paul Pais De Barros, Naig Le Guern, Laure Dumont, Martina Schneider, Valérie Risson, Philippe Moulin, Delphine Autran, Gillian Brooker, Jean Sassard, Alain Bataillard.   

Abstract

In order to investigate the direct effect of cholesteryl ester transfer protein (CETP) on the structure and composition of HDL in vivo, simian CETP was expressed in Fisher rat that spontaneously displays high plasma levels of HDL1. In the new CETPTg rat line, the production of active CETP by the liver induced a significant 48% decrease in plasma HDL cholesterol, resulting in a 34% decrease in total cholesterol level (P < 0.01 in both cases). Among the various plasma HDL subpopulations, the largest HDL were those mostly affected by CETP, with a 74% decrease in HDL1 versus a significantly weaker 38% decrease in smaller HDL2 (P < 0.0001). Apolipoprotein E (apoE)-containing HDL1 were selectively affected by CETP expression, whereas apoA content of HDL remained unmodified. The reduction in the apoE content of serum HDL observed in CETPTg rats compared to controls (53%, P < 0.02) suggests that apoE in HDL may constitute in vivo a major determinant of their ability to interact with CETP. These results bring new insight into the lack of HDL1 in plasma from CETP-deficient heterozygotes despite their substantial 50% decrease in CETP activity. In addition, they indicate that HDL1 constitute reliable and practicable sensors of very low plasma CETP activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454279     DOI: 10.1194/jlr.m200253-jlr200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile.

Authors:  Lan Wang; Chuan-Ming Li; Martin Rudolf; Olga V Belyaeva; Byung Hong Chung; Jeffrey D Messinger; Natalia Y Kedishvili; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

3.  HDL and Cholesterol Ester Transfer Protein (CETP).

Authors:  Siying Deng; Jiewen Liu; Chenguang Niu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver.

Authors:  Stella M Daniele; Silvana M Montenegro; María C Tarres; Juan C Picena; Stella M Martinez
Journal:  Diabetol Metab Syndr       Date:  2010-03-17       Impact factor: 3.320

Review 5.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

6.  Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 2. ApoE and apoC-III relations in triglyceride clearance.

Authors:  Alexander D Dergunov; Anne Ponthieux; Maxim V Mel'kin; Daniel Lambert; Olga Yu Sokolova; Nadir M Akhmedzhanov; Sophie Visvikis-Siest; Gerard Siest
Journal:  Mol Cell Biochem       Date:  2009-01-13       Impact factor: 3.396

7.  Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein.

Authors:  Yi-Qiang Liang; Masato Isono; Tadashi Okamura; Fumihiko Takeuchi; Norihiro Kato
Journal:  Hypertens Res       Date:  2020-01-24       Impact factor: 3.872

Review 8.  Cholesterol in the retina: the best is yet to come.

Authors:  Irina A Pikuleva; Christine A Curcio
Journal:  Prog Retin Eye Res       Date:  2014-04-04       Impact factor: 21.198

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.